Creative Medical Technology Announces Positive Top-Line Results for StemSpine® Pilot Study - Yahoo Finance

Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company ...

--Two-Year Follow-Up Results Confirm Significant Efficacy and No Serious Adverse Effects in Patients Using StemSpine® Procedure for Treating Chronic Lower Back Pain -- PHOENIX, March 23, 2022 /PRNew… [+3664 chars]

full article...